Jeffrey S. Heier, Chief Scientific Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 2,948 shares at $9.01 ($27K) on 2024-11-25, disclosed to the SEC on 2024-11-27.
Open-market sale of $27k OCUL by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OCUL | SELL | 2026-05-28 | $25K | — | Filing → |
| OCUL | SELL | 2026-02-25 | $25K | — | Filing → |
| OCUL | SELL | 2025-11-26 | $42K | — | Filing → |